肾功能衰竭患者及血液透析期间莫西拉坦的药代动力学
Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
作者信息
Srinivasan S, Neu H C
出版信息
Antimicrob Agents Chemother. 1981 Sep;20(3):398-400. doi: 10.1128/AAC.20.3.398.
Abstract
The pharmacokinetics of moxalactam were determined in eight patients with end stage renal disease who were undergoing chronic hemodialysis. The mean half-life of moxalactam in the interdialysis period was 19 h, with a range of 9 to 30 h. The mean half-life of moxalactam during dialysis was 4 +/- 0.58 h. Serum levels of 30 +/- 10 micrograms/ml were present 24 h after a 1-g dose in the interdialysis period. A dose of 1 g at the end of each dialysis period in patients undergoing thrice-weekly hemodialysis would provide levels far in excess of the minimal inhibitory levels against Enterobacteriaceae.
摘要
测定了8例终末期肾病且正在接受慢性血液透析患者的拉氧头孢的药代动力学。透析间期拉氧头孢的平均半衰期为19小时，范围为9至30小时。透析期间拉氧头孢的平均半衰期为4±0.58小时。透析间期给予1g剂量后24小时血清水平为30±10μg/ml。对于每周进行三次血液透析的患者，在每次透析结束时给予1g剂量，其血药浓度将远远超过对肠杆菌科细菌的最低抑菌浓度。
相似文献
1
Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.肾功能衰竭患者及血液透析期间莫西拉坦的药代动力学
Antimicrob Agents Chemother. 1981 Sep;20(3):398-400. doi: 10.1128/AAC.20.3.398.
2
Moxalactam pharmacokinetics during hemodialysis.血液透析期间的头孢氧哌唑药代动力学。
Antimicrob Agents Chemother. 1981 Apr;19(4):575-7. doi: 10.1128/AAC.19.4.575.
3
Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.正常受试者和肾衰竭受试者中莫西拉坦的药代动力学、蛋白结合及预计的血管外分布
Antimicrob Agents Chemother. 1981 Sep;20(3):378-81. doi: 10.1128/AAC.20.3.378.
4
The pharmacokinetics of moxalactam in renal failure.莫西拉坦在肾衰竭患者中的药代动力学。
J Antimicrob Chemother. 1981 Nov;8(5):395-9. doi: 10.1093/jac/8.5.395.
5
[Pharmacokinetics of moxalactam in adults].[成人莫西拉坦的药代动力学]
Sem Hop. 1983 Jun 30;59(26):1963-7.
6
Pharmacokinetics of moxalactam in patients with renal insufficiency.肾功能不全患者中莫西拉坦的药代动力学。
Antimicrob Agents Chemother. 1981 Mar;19(3):461-4. doi: 10.1128/AAC.19.3.461.
7
Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.正常肾功能和肾功能受损受试者中莫拉卡坦的药代动力学。
Antimicrob Agents Chemother. 1981 Jun;19(6):965-71. doi: 10.1128/AAC.19.6.965.
8
Moxalactam kinetics in hemodialysis.
Clin Pharmacol Ther. 1981 Oct;30(4):487-90. doi: 10.1038/clpt.1981.192.
9
Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.正常志愿者中莫西拉坦与头孢唑林的药代动力学比较。
Antimicrob Agents Chemother. 1981 Feb;19(2):302-5. doi: 10.1128/AAC.19.2.302.
10
Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
Clin Pharmacol Ther. 1983 Sep;34(3):403-7. doi: 10.1038/clpt.1983.187.
引用本文的文献
1
Pharmacokinetics of moxalactam in elderly subjects.老年人中莫西拉坦的药代动力学
Antimicrob Agents Chemother. 1984 Jan;25(1):33-6. doi: 10.1128/AAC.25.1.33.
2
The use of moxalactam in the treatment of serious infections due to multi-resistant organisms.羟羧氧酰胺菌素在治疗多重耐药菌引起的严重感染中的应用。
Infection. 1983 Nov-Dec;11(6):291-5. doi: 10.1007/BF01641349.
3
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
本文引用的文献
1
Pharmacokinetics of moxalactam in patients with renal insufficiency.肾功能不全患者中莫西拉坦的药代动力学。
Antimicrob Agents Chemother. 1981 Mar;19(3):461-4. doi: 10.1128/AAC.19.3.461.
2
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.不同程度肾功能不全患者中莫西拉坦的药代动力学
Antimicrob Agents Chemother. 1980 Dec;18(6):933-8. doi: 10.1128/AAC.18.6.933.
3
Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.新型1-氧杂-β-内酰胺（LY127935）在正常志愿者中的药理学研究。
Antimicrob Agents Chemother. 1980 Feb;17(2):226-8. doi: 10.1128/AAC.17.2.226.
4
Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.慢性血液透析患者静脉注射头孢噻肟的药代动力学
Ther Drug Monit. 1981;3(1):71-4.
5
Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.正常志愿者中莫西拉坦与头孢唑林的药代动力学比较。
Antimicrob Agents Chemother. 1981 Feb;19(2):302-5. doi: 10.1128/AAC.19.2.302.
6
Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients.头孢西丁钠在正常受试者和尿毒症患者中的药代动力学。
J Antimicrob Chemother. 1978 Jul;4(B):79-83. doi: 10.1093/jac/4.suppl_b.79.
7
Pharmacokinetics of cefotaxime.头孢噻肟的药代动力学。
Antimicrob Agents Chemother. 1979 Nov;16(5):592-7. doi: 10.1128/AAC.16.5.592.
8
Pharmacokinetics of cephalosporin antibiotics.头孢菌素类抗生素的药代动力学
Antibiot Chemother (1971). 1978;25:123-62. doi: 10.1159/000401060.
9
Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.一种新型1-氧杂头孢菌素与其他β-内酰胺类化合物的抗菌活性比较。
Antimicrob Agents Chemother. 1979 Aug;16(2):141-9. doi: 10.1128/AAC.16.2.141.
Zotero 插件